• 1. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Morpholine, 4-(3-pyridinyl)- (CAS No. 92670-29-6): A Comprehensive Overview of Its Applications and Recent Research Developments

Morpholine, 4-(3-pyridinyl)-, identified by its CAS number 92670-29-6, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its pyridine and morpholine moieties, exhibits a unique structural framework that makes it a versatile intermediate in the synthesis of various bioactive molecules. The combination of these two heterocyclic systems imparts distinct chemical properties, making it a valuable building block for drug discovery and development.

The< strong>Morpholine, 4-(3-pyridinyl)- core structure is derived from the pyridine ring, which is a common pharmacophore in many therapeutic agents, and the morpholine ring, known for its ability to enhance solubility and bioavailability. This dual functionality has positioned this compound as a key intermediate in the synthesis of novel pharmaceuticals targeting various diseases. Recent advancements in synthetic methodologies have further expanded its utility, allowing for more efficient and scalable production processes.

In the realm of pharmaceutical research, Morpholine, 4-(3-pyridinyl)- has been extensively explored for its potential in developing new therapeutic agents. Its structural features make it an excellent candidate for designing molecules with enhanced binding affinity and selectivity. For instance, studies have demonstrated its role in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The pyridine moiety can interact with specific amino acid residues in target proteins, while the morpholine ring contributes to optimal pharmacokinetic properties.

One of the most compelling aspects of Morpholine, 4-(3-pyridinyl)- is its versatility in drug design. Researchers have leveraged its scaffold to develop compounds with diverse biological activities. Notably, recent studies have highlighted its application in creating potent antiviral agents. The ability of this compound to modulate viral protease enzymes has shown promise in combating emerging infectious diseases. Additionally, its role in developing central nervous system (CNS) drugs has been investigated, with preliminary findings suggesting its potential in treating neurodegenerative disorders.

The synthesis of Morpholine, 4-(3-pyridinyl)- involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced catalytic systems and green chemistry principles have been employed to optimize these processes. For example, transition metal-catalyzed cross-coupling reactions have been utilized to construct the pyridine-morpholine core efficiently. These methods not only improve the synthetic route but also minimize waste generation, aligning with sustainable chemistry practices.

The pharmacological profile of Morpholine, 4-(3-pyridinyl)- has been thoroughly examined through both in vitro and in vivo studies. Its interaction with biological targets has been mapped using computational modeling techniques, providing insights into its mechanism of action. These studies have revealed that the compound can exhibit multiple modes of binding, enhancing its therapeutic potential. Furthermore, pharmacokinetic studies have indicated favorable absorption, distribution, metabolism, and excretion (ADME) properties, making it an attractive candidate for clinical development.

Recent clinical trials have begun to explore the efficacy of derivatives of Morpholine, 4-(3-pyridinyl)- in treating various diseases. Preliminary results suggest that certain analogs exhibit significant therapeutic effects with minimal side effects. These findings underscore the importance of this compound as a lead molecule for drug discovery programs. As research continues to uncover new applications, the demand for high-quality Morpholine, 4-(3-pyridinyl)- is expected to grow.

The industrial production of Morpholine, 4-(3-pyridinyl)- has also seen advancements due to innovations in chemical manufacturing technologies. Continuous flow reactors and automated synthesis platforms have enabled large-scale production with improved consistency and cost-efficiency. These advancements ensure that researchers and pharmaceutical companies have access to sufficient quantities of this critical intermediate for their studies.

In conclusion, Morpholine, 4-(3-pyridinyl)- (CAS No. 92670-29-6) is a multifaceted compound with significant potential in pharmaceutical applications. Its unique structural features and diverse biological activities make it a valuable tool for drug discovery and development. With ongoing research efforts aimed at uncovering new therapeutic uses and optimizing synthetic methodologies, this compound is poised to play a pivotal role in addressing global health challenges.

• 823202-94-4(1,4,7,10-Tetraoxa-13-azacyclopentadecane, 13-(3-pyridinyl)-)
• 1313726-73-6(N3-(2-methoxyethyl)-3,5-Pyridinediamine)
• 1354940-70-7(2-Amino-5-morpholinopyridine Hydrochloride)
• 2767-91-1(4-(Pyridin-4-yl)morpholine)
• 571189-78-1(5-Morpholinopyridin-2-amine)
• 501954-43-4(Isoquinoline, 4-(4-morpholinyl)-)
• 364763-44-0(5-Morpholinopyridin-3-ol)
• 78070-10-7(3-Pyridinamine,4-(4-morpholinyl)-, hydrochloride (1:2))
• 137794-83-3(Quinoline, 3-(4-morpholinyl)-)
• 90648-26-3(4-(morpholin-4-yl)pyridin-3-amine)